Improved overall survival with enasidenib compared with standard of care among patients with relapsed or refractory acute myeloid leukemia and IDH2 mutations: A propensity score matching analysis using data from the AG221-C-001 trial and two data sources from France and Germany Meeting Abstract
| Authors: | De Botton, S.; Brandwein, J. M.; Stein, E. M.; Wei, A. H.; Weber, D.; Pigneux, A.; Boissel, N.; Paschka, P.; Döhner, K.; Nehme, S. A.; Frattini, M. G.; Marion-Gallois, R.; Wang, J.; Cameron, C.; Siddiqui, M.; Qadeer, R. A.; Döhner, H. |
| Abstract Title: | Improved overall survival with enasidenib compared with standard of care among patients with relapsed or refractory acute myeloid leukemia and IDH2 mutations: A propensity score matching analysis using data from the AG221-C-001 trial and two data sources from France and Germany |
| Meeting Title: | 61st Annual Meeting and Exposition of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 134 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2019 Dec 7-10 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2019-11-13 |
| Language: | English |
| ACCESSION: | WOS:000577164601186 |
| DOI: | 10.1182/blood-2019-122700 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3893 -- Source: Wos |
